289 related articles for article (PubMed ID: 29955370)
1. TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
Idborg H; Eketjäll S; Pettersson S; Gustafsson JT; Zickert A; Kvarnström M; Oke V; Jakobsson PJ; Gunnarsson I; Svenungsson E
Lupus Sci Med; 2018; 5(1):e000260. PubMed ID: 29955370
[TBL] [Abstract][Full Text] [Related]
2. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus.
Ruacho G; Lira-Junior R; Gunnarsson I; Svenungsson E; Boström EA
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35246487
[TBL] [Abstract][Full Text] [Related]
4. Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.
Svenungsson E; Gunnarsson I; Illescas-Bäckelin V; Trysberg E; Jönsen A; Leonard D; Sjöwall C; Pettersson S
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33972457
[TBL] [Abstract][Full Text] [Related]
5. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
7. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
Front Immunol; 2021; 12():688753. PubMed ID: 34276678
[TBL] [Abstract][Full Text] [Related]
9. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.
Postal M; Ruocco HH; Brandão CO; Costallat LTL; Silva L; Cendes F; Appenzeller S
Neuroimmunomodulation; 2017; 24(2):100-105. PubMed ID: 28848179
[TBL] [Abstract][Full Text] [Related]
12. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
13. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
Adel Y; Sadeq Y
Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
[TBL] [Abstract][Full Text] [Related]
14. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
Pettersson S; Svenungsson E; Gustafsson J; Möller S; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2017 Nov; 46(6):474-483. PubMed ID: 28293972
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
16. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
Saeed AM; Mogahed MM
Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
[TBL] [Abstract][Full Text] [Related]
17. Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus.
Asano T; Matsuoka N; Fujita Y; Matsumoto H; Temmoku J; Yashiro-Furuya M; Sato S; Suzuki E; Kobayashi H; Watanabe H; Migita K
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167436
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
[TBL] [Abstract][Full Text] [Related]
19. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
20. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
Thanou A; Stavrakis S; Dyer JW; Munroe ME; James JA; Merrill JT
Arthritis Res Ther; 2016 Sep; 18(1):197. PubMed ID: 27590046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
